Transoral laser microsurgery followed by radiation therapy for oropharyngeal tumors: The mayo clinic arizona experience

Head and Neck

Volumn 36, Issue 2, 2014, Pages 220-225

  Patel, Samir H ^a   Hinni, Michael L ^a   Hayden, Richard E ^a   Wong, William W ^a   Dueck, Amylou C ^a   Zarka, Matthew A ^a   Curtis, Kelly K ^a   Halyard, Michele Y ^a  

^a MAYO CLINIC   (United States)

Author keywords

head neck cancer; oropharyngeal; radiation; transoral; transoral laser microsurgery

Indexed keywords

CETUXIMAB; CISPLATIN;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LIVER FAILURE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; ORAL SURGERY; OROPHARYNX CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; TRANSORAL LASER MICROSURGERY; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

HEAD NECK CANCER; OROPHARYNGEAL; RADIATION; TRANSORAL; TRANSORAL LASER MICROSURGERY;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; ARIZONA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASER THERAPY; MALE; MICROSURGERY; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; POSTOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84892438699     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23279     Document Type: Article

References (20)

1. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720.
2. Steiner W, Fierek O, Ambrosch P, Hommerich CP, Kron M,. Transoral laser microsurgery for squamous cell carcinoma of the base of the tongue. Arch Otolaryngol Head Neck Surg 2003; 129: 36-43.
3. Parsons JT, Mendenhall WM, Stringer SP, et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer 2002; 94: 2967-2980.
4. Rich JT, Milov S, Lewis JS Jr, Thorstad WL, Adkins DR, Haughey BH,. Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors. Laryngoscope 2009; 119: 1709-1719.
5. Haughey BH, Hinni ML, Salassa JR, et al. Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck 2011; 33: 1683-1694.
6. Grant DG, Salassa JR, Hinni ML, Pearson BW, Perry WC,. Carcinoma of the tongue base treated by transoral laser microsurgery, part one: untreated tumors, a prospective analysis of oncologic and functional outcomes. Laryngoscope 2006; 116: 2150-2155.
7. Christiansen H, Hermann RM, Martin A, et al. Long-term follow-up after transoral laser microsurgery and adjuvant radiotherapy for advanced recurrent squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2006; 65: 1067-1074.
8. Pradier O, Christiansen H, Schmidberger H, et al. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2005; 63: 1368-1377.
9. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 2005; 27: 843-850.
10. Weinstein GS, O'Malley BW Jr, Cohen MA, Quon H,. Transoral robotic surgery for advanced oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2010; 136: 1079-1085.
11. Setton J, Caria N, Romanyshyn J, et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2012; 82: 291-298.
12. Hong AM, Dobbins TA, Lee CS, et al. Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer 2010; 103: 1510-1517.
13. Ang KK, Sturgis EM,. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol 2012; 22: 128-142.
14. Weinstein GS, Quon H, O'Malley BW Jr, Kim GG, Cohen MA,. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial. Laryngoscope 2010; 120: 1749-1755.
15. Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol 2010; 28: 2732-2738.
16. Levendag PC, Teguh DN, Voet P, et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship. Radiother Oncol 2007; 85: 64-73.
17. Fletcher GH, Evers WT,. Radiotherapeutic management of surgical recurrences and postoperative residuals in tumors of the head and neck. Radiology 1970; 95: 185-188.
18. Quon H, O'Malley BW Jr, Weinstein GS,. Postoperative adjuvant therapy after transoral robotic resection for oropharyngeal carcinomas: rationale and current treatment approach. ORL J Otorhinolaryngol Relat Spec 2011; 73: 121-130.
19. Grant DG, Hinni ML, Salassa JR, Perry WC, Hayden RE, Casler JD,. Oropharyngeal cancer: a case for single modality treatment with transoral laser microsurgery. Arch Otolaryngol Head Neck Surg 2009; 135: 1225-1230.
20. Moore EJ, Hinni ML, Olsen KD, Price DL, Laborde RR, Inman JC,. Cost considerations in the treatment of oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 2012; 146: 946-951.